• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内评估前列腺癌转移细胞潜能。

In Vivo Assessment of Metastatic Cell Potential in Prostate Cancer.

机构信息

Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.

CIBERONC, Madrid, Spain.

出版信息

Methods Mol Biol. 2021;2294:253-267. doi: 10.1007/978-1-0716-1350-4_18.

DOI:10.1007/978-1-0716-1350-4_18
PMID:33742407
Abstract

Metastasis is the main cause of death for cancer patients, but our ability to improve clinical outcome first requires a better understanding of the dynamics, cellular mechanisms, and kinetics of metastasis. In prostate cancer (PCa), metastatic tumor cells preferentially colonize to bone. However, a lack of applicable mouse models has limited our ability to study this process accurately. Here, we describe a strategy to bypass this limitation: human PCa cells are injected into immunodeficient mice (at tibia, the left ventricle of heart and the iliac artery). Using this novel technique, the metastatic capabilities of these human PCa cells (e.g., colonization and proliferation potential) can be analyzed in bone with an in vivo imaging system.

摘要

转移是癌症患者死亡的主要原因,但要提高临床疗效,首先需要更好地了解转移的动力学、细胞机制和动力学。在前列腺癌(PCa)中,转移性肿瘤细胞优先定植于骨骼。然而,缺乏适用的小鼠模型限制了我们准确研究这一过程的能力。在这里,我们描述了一种克服这一限制的策略:将人 PCa 细胞注射到免疫缺陷小鼠(胫骨、左心室和髂动脉)中。使用这种新技术,可以使用体内成像系统分析这些人 PCa 细胞在骨骼中的转移能力(例如定植和增殖潜力)。

相似文献

1
In Vivo Assessment of Metastatic Cell Potential in Prostate Cancer.体内评估前列腺癌转移细胞潜能。
Methods Mol Biol. 2021;2294:253-267. doi: 10.1007/978-1-0716-1350-4_18.
2
Models of Prostate Cancer Bone Metastasis.前列腺癌骨转移模型
Methods Mol Biol. 2019;1914:295-308. doi: 10.1007/978-1-4939-8997-3_16.
3
Animal models of bone metastasis.骨转移的动物模型
Cancer. 2003 Feb 1;97(3 Suppl):748-57. doi: 10.1002/cncr.11150.
4
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.前列腺癌骨转移中的基质金属蛋白酶活性、骨基质周转及肿瘤细胞增殖
J Natl Cancer Inst. 2002 Jan 2;94(1):17-25. doi: 10.1093/jnci/94.1.17.
5
Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.靶向组织蛋白酶 K 可减少鼠骨中前列腺癌的建立和生长。
J Cancer Res Clin Oncol. 2019 Aug;145(8):1999-2012. doi: 10.1007/s00432-019-02950-y. Epub 2019 Jun 6.
6
Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.评估严重联合免疫缺陷(SCID)小鼠体内人胎儿骨植入物作为前列腺癌骨转移模型的情况。
Oncol Rep. 2006 Mar;15(3):519-24.
7
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.人前列腺癌转移至人骨的严重联合免疫缺陷-人模型
Cancer Res. 1999 Apr 15;59(8):1987-93.
8
Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.骨形态发生蛋白对转移性前列腺癌中成骨细胞性病变形成的影响。
J Bone Miner Res. 2005 Dec;20(12):2189-99. doi: 10.1359/JBMR.050802. Epub 2005 Aug 1.
9
Non-invasive microCT imaging characterization and in vivo targeting of BB2 receptor expression of a PC-3 bone metastasis model.非侵入性 microCT 成像特征分析及 BB2 受体在 PC-3 骨转移模型中的体内靶向性研究。
Mol Imaging Biol. 2012 Dec;14(6):667-75. doi: 10.1007/s11307-012-0540-8.
10
A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.一种用于可控研究体内肿瘤-基质相互作用的患者来源前列腺癌异种移植的3D体外模型。
Biomaterials. 2016 Jan;77:164-72. doi: 10.1016/j.biomaterials.2015.10.059. Epub 2015 Nov 9.

引用本文的文献

1
Orthotopic and metastatic tumour models in preclinical cancer research.临床前癌症研究中的原位和转移瘤模型。
Pharmacol Ther. 2024 May;257:108631. doi: 10.1016/j.pharmthera.2024.108631. Epub 2024 Mar 11.
2
Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.微小RNA-135b缺失增强前列腺癌骨转移并预测人类前列腺样本的侵袭性。
Cancers (Basel). 2021 Dec 9;13(24):6202. doi: 10.3390/cancers13246202.

本文引用的文献

1
Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.LKB1 的基因操作会引发致命转移性前列腺癌。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20191787.
2
From latency to overt bone metastasis in breast cancer: potential for treatment and prevention.从乳腺癌的潜伏期到明显的骨转移:治疗和预防的潜力。
J Pathol. 2019 Sep;249(1):6-18. doi: 10.1002/path.5292. Epub 2019 Jun 27.
3
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.
PROREPAIR-B:胚系 DNA 修复突变对转移性去势抵抗性前列腺癌患者结局影响的前瞻性队列研究。
J Clin Oncol. 2019 Feb 20;37(6):490-503. doi: 10.1200/JCO.18.00358. Epub 2019 Jan 9.
4
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.阿比特龙用于既往未接受过激素治疗的前列腺癌患者
N Engl J Med. 2017 Jul 27;377(4):338-351. doi: 10.1056/NEJMoa1702900. Epub 2017 Jun 3.
5
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.Rb1和Trp53协同作用以抑制前列腺癌的谱系可塑性、转移和抗雄激素耐药性。
Science. 2017 Jan 6;355(6320):78-83. doi: 10.1126/science.aah4199.
6
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.代谢协同调节因子PGC1α可抑制前列腺癌转移。
Nat Cell Biol. 2016 Jun;18(6):645-656. doi: 10.1038/ncb3357. Epub 2016 May 23.
7
Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.MYC激活与Pten缺失共同作用足以引发基因组不稳定和致命性转移性前列腺癌。
Cancer Res. 2016 Jan 15;76(2):283-92. doi: 10.1158/0008-5472.CAN-14-3280. Epub 2015 Nov 10.
8
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.转移性激素敏感性前列腺癌的化学激素疗法
N Engl J Med. 2015 Aug 20;373(8):737-46. doi: 10.1056/NEJMoa1503747. Epub 2015 Aug 5.
9
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
10
High-risk prostate cancer-classification and therapy.高危前列腺癌——分类与治疗
Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20.